Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18507396rdf:typepubmed:Citationlld:pubmed
pubmed-article:18507396lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C0019143lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C0011602lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C0003595lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C0597298lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C0597731lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:18507396lifeskim:mentionsumls-concept:C1707271lld:lifeskim
pubmed-article:18507396pubmed:issue25lld:pubmed
pubmed-article:18507396pubmed:dateCreated2010-3-24lld:pubmed
pubmed-article:18507396pubmed:abstractTextThe ability of apolipoprotein E (apoE) to bind to cell-surface glycosaminoglycans (GAGs) is important for lipoprotein remnant catabolism. Using surface plasmon resonance, we previously showed that the binding of apoE to heparin is a two-step process; the initial binding involves fast electrostatic interaction, followed by a slower hydrophobic interaction. Here we examined the contributions of the N- and C-terminal domains to each step of the binding of apoE isoforms to heparan sulfate (HS) and dermatan sulfate (DS). ApoE3 bound to less sulfated HS and DS with a decreased favorable free energy of binding in the first step compared to heparin, indicating that the degree of sulfation has a major effect on the electrostatic interaction of GAGs with apoE. Mutation of a key Lys residue in the N-terminal heparin binding site of apoE significantly affected this electrostatic interaction. Progressive truncation of the C-terminal alpha-helical regions which favors the monomeric form of apoE3 greatly weakened the ability of apoE3 to bind to HS, with a much reduced favorable free energy of binding of the first step, suggesting that the C-terminal domain contributes to the GAG binding of apoE by the oligomerization effect. In agreement with this, dimerization of the apoE3 N-terminal fragment via disulfide linkage restored the electrostatic interaction of apoE with HS. Significantly, apoE4 exhibited much stronger binding to HS and DS than apoE2 or apoE3 in both lipid-free and lipidated states, perhaps resulting from enhanced electrostatic interaction through the N-terminal domain. This isoform difference in GAG binding of apoE may be physiologically significant such as in the retention of apoE-containing lipoproteins in the arterial wall.lld:pubmed
pubmed-article:18507396pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:languageenglld:pubmed
pubmed-article:18507396pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:citationSubsetIMlld:pubmed
pubmed-article:18507396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18507396pubmed:statusMEDLINElld:pubmed
pubmed-article:18507396pubmed:monthJunlld:pubmed
pubmed-article:18507396pubmed:issn1520-4995lld:pubmed
pubmed-article:18507396pubmed:authorpubmed-author:Lund-KatzSiss...lld:pubmed
pubmed-article:18507396pubmed:authorpubmed-author:PhillipsMicha...lld:pubmed
pubmed-article:18507396pubmed:authorpubmed-author:TanakaMasafum...lld:pubmed
pubmed-article:18507396pubmed:authorpubmed-author:SaitoHiroyuki...lld:pubmed
pubmed-article:18507396pubmed:authorpubmed-author:NakanoMinoruMlld:pubmed
pubmed-article:18507396pubmed:authorpubmed-author:HandaTetsurou...lld:pubmed
pubmed-article:18507396pubmed:authorpubmed-author:YamauchiYukoYlld:pubmed
pubmed-article:18507396pubmed:authorpubmed-author:DhanasekaranP...lld:pubmed
pubmed-article:18507396pubmed:authorpubmed-author:TakagiChikaClld:pubmed
pubmed-article:18507396pubmed:authorpubmed-author:DeguchiNoriko...lld:pubmed
pubmed-article:18507396pubmed:issnTypeElectroniclld:pubmed
More...